Embla Medical hf. (CPH:EMBLA)

Market Cap	11.67B -17.4%
Revenue (ttm)	5.91B +8.6%
Net Income	530.09M +22.1%
EPS	1.24 +22.0%
Shares Out	427.35M
PE Ratio	21.99
Forward PE	18.19
Dividend	n/a
Ex-Dividend Date	n/a

Volume	42,415
Average Volume	52,581
Open	27.10
Previous Close	27.30
Day's Range	26.80 - 27.30
52-Week Range	25.01 - 37.90
Beta	0.43
RSI	26.35
Earnings Date	Apr 28, 2026

About Embla Medical

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products, such as microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints. The Bracing and Supports segment provides os...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1971
• Employees: 4,195
• Stock Exchange: Copenhagen Stock Exchange
• Ticker Symbol: EMBLA

Financial Performance

In 2025, Embla Medical's revenue was $928.69 million, an increase of 8.63% compared to the previous year's $854.89 million. Earnings were $83.34 million, an increase of 22.05%.

Financial numbers in USD